Literature DB >> 20699256

Inflammatory and prothrombotic activation with conserved endothelial function in patients with chronic, asymptomatic Chagas disease.

Ramón N Herrera1, Elba I Díaz de Amaya, Rossana C Pérez Aguilar, Claudio Joo Turoni, Rodrigo Marañón, Sofía G Berman, Héctor L Luciardi, Alfredo Coviello, María Peral de Bruno.   

Abstract

UNLABELLED: Previously, our group showed a prothrombotic state in asymptomatic patients with chronic Chagas disease. The current paper studies the inflammatory status and endothelial function in these patients.
METHODS: In 40 patients and 40 healthy volunteers, we evaluated prothrombotic state, blood parasitemia (molecular biology: polymerized chain reaction [PCR]-amplification), tissue factor pathway inhibitor antibodies (aTFPI), interleukin 6 (IL-6), and vascular cell adhesion molecule-1 (VCAM-1). Endothelial function was determined by reactive hyperemia (pulse plethysmography).
RESULTS: In patients, prothrombin fragment 1 + 2, d-dimer, PAI-1, and fibrinogen were higher. Amplification of 121/122 primers (Trypanosoma cruzi) was positive in 45% of the patients. Patients presented higher values of aTFPI- immunoglobulin G (IgG; P < .05), aTFPI-IgM (P < .001), IL-6 (P = .004), and VCAM-1 (P = .00001). In both groups, endothelial function was preserved.
CONCLUSIONS: We found that asymptomatic patients with chronic Chagas disease presented a prothrombotic/inflammatory status. The fact that endothelial function is still preserved suggests that prothrombosis and inflammation are primarily implicated in the beginning of cardiovascular damage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20699256     DOI: 10.1177/1076029610375814

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  9 in total

Review 1.  Re. Re.: "Immunothrombotic dysregulation in Chagas disease and COVID19: a comparative study of anticoagulation".

Authors:  Laura Pérez-Campos Mayoral; María Teresa Hernández-Huerta; Eduardo Pérez-Campos Mayoral; Carlos Alberto Matias Cervantes; Eduardo Pérez-Campos
Journal:  Mol Cell Biochem       Date:  2022-07-13       Impact factor: 3.842

2.  Stroke in Chagas disease: from pathophysiology to clinical practice.

Authors:  Thaís Aparecida Reis Lage; Julia Teixeira Tupinambás; Lucas Bretas de Pádua; Matheus de Oliveira Ferreira; Amanda Cambraia Ferreira; Antonio Lucio Teixeira; Maria Carmo Pereira Nunes
Journal:  Rev Soc Bras Med Trop       Date:  2022-06-06       Impact factor: 2.141

3.  The role of vascular endothelium and exosomes in human protozoan parasitic diseases.

Authors:  Sanjay Varikuti; Bijay Kumar Jha; Erin A Holcomb; Jodi C McDaniel; Manjula Karpurapu; Nidhi Srivastava; Bradford S McGwire; Abhay R Satoskar; Narasimham L Parinandi
Journal:  Vessel Plus       Date:  2020-09-27

4.  Protection of vascular endothelium by aspirin in a murine model of chronic Chagas' disease.

Authors:  Alfredo Molina-Berríos; Carolina Campos-Estrada; Michel Lapier; Juan Duaso; Ulrike Kemmerling; Norbel Galanti; Jorge Ferreira; Antonio Morello; Rodrigo López-Muñoz; Juan Diego Maya
Journal:  Parasitol Res       Date:  2013-05-17       Impact factor: 2.289

5.  Altered Hypercoagulability Factors in Patients with Chronic Chagas Disease: Potential Biomarkers of Therapeutic Response.

Authors:  Maria-Jesus Pinazo; Elizabeth de Jesus Posada; Luis Izquierdo; Dolors Tassies; Alexandre-Ferreira Marques; Elisa de Lazzari; Edelweiss Aldasoro; Jose Muñoz; Alba Abras; Silvia Tebar; Montserrat Gallego; Igor Correia de Almeida; Joan-Carles Reverter; Joaquim Gascon
Journal:  PLoS Negl Trop Dis       Date:  2016-01-04

Review 6.  Infectious myocarditis: the role of the cardiac vasculature.

Authors:  Linde Woudstra; Lynda J M Juffermans; Albert C van Rossum; Hans W M Niessen; Paul A J Krijnen
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214

7.  Oral Route Driven Acute Trypanosoma cruzi Infection Unravels an IL-6 Dependent Hemostatic Derangement.

Authors:  Dina Antunes; Alessandro Marins-Dos-Santos; Mariana Tavares Ramos; Barbara Angelica S Mascarenhas; Carlos José de Carvalho Moreira; Désio Aurélio Farias-de-Oliveira; Wilson Savino; Robson Q Monteiro; Juliana de Meis
Journal:  Front Immunol       Date:  2019-05-14       Impact factor: 7.561

Review 8.  Chagas heart disease: An overview of diagnosis, manifestations, treatment, and care.

Authors:  Roberto M Saraiva; Mauro Felippe F Mediano; Fernanda Sns Mendes; Gilberto Marcelo Sperandio da Silva; Henrique H Veloso; Luiz Henrique C Sangenis; Paula Simplício da Silva; Flavia Mazzoli-Rocha; Andréa S Sousa; Marcelo T Holanda; Alejandro M Hasslocher-Moreno
Journal:  World J Cardiol       Date:  2021-12-26

9.  Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation.

Authors:  Laura Pérez-Campos Mayoral; María Teresa Hernández-Huerta; Dulce Papy-García; Denis Barritault; Edgar Zenteno; Luis Manuel Sánchez Navarro; Eduardo Pérez-Campos Mayoral; Carlos Alberto Matias Cervantes; Margarito Martínez Cruz; Gabriel Mayoral Andrade; Malaquías López Cervantes; Gabriela Vázquez Martínez; Claudia López Sánchez; Socorro Pina Canseco; Ruth Martínez Cruz; Eduardo Pérez-Campos
Journal:  Mol Cell Biochem       Date:  2021-06-10       Impact factor: 3.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.